AKT1 and choroidal melanoma: In choroidal melanoma, artemisinin can target the PI3K/AKT/mTOR signaling pathway to exert tumor growth inhibition [166]while artesunate combined with venetoclax can regulate the MALAT918/YAP signaling pathway to inhibit cell viability [170].